Table 2.
Characteristics of Vaccinated Participants (n = 662).
| Variables | Participants, n (%) | |
|---|---|---|
| Reasons for vaccination | Immune from COVID-19 | 422 (40.04) |
| Supporting the vaccination policies | 507 (48.10) | |
| Requirement of workplace | 125 (11.86) | |
| Manufacturer of vaccines | Tianjin Cansino Biotechnology Inc. | 25 (3.78) |
| Beijing Institute of Biological Products Co., Ltd. | 39 (5.89) | |
| Wuhan Institute of Biological Products and Wuhan Institute of Virology | 103 (15.56) | |
| Sinovac Biotech Co., Ltd. | 335 (50.60) | |
| Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. | 83 (12.54) | |
| Other manufacturers | 11 (1.66) | |
| No knowledge of the manufacturer | 66 (9.97) | |
| The primary vaccination progress | Completed partial injections | 530 (80.06) |
| Completed all injections | 132 (19.94) | |
| Organizer of vaccination | Community | 281 (42.45) |
| School | 176 (26.59) | |
| Workplace | 189 (28.55) | |
| Other organizers | 16 (2.42) | |
| Source of vaccine information | Reports from the official online media | 637 (34.98) |
| Authoritative News media | 522 (28.67) | |
| Social media | 382 (20.98) | |
| Short video applications | 118 (6.48) | |
| Recommendation of web pages | 55 (3.02) | |
| Online health community | 93 (5.11) | |
| Other sources | 14 (0.77) |